Enantiomeric separation of d,l-tryptophan and d,l-kynurenine by HPLC using pre-column fluorescence derivatization with R(-)-DBD-PyNCS

Biomedical Chromatography

Volumn 25, Issue 7, 2011, Pages 743-747

  Iizuka, Hideaki ^a   Hirasa, Yasushi ^a   Kubo, Kazumi ^a   Ishii, Kana ^a   Toyo'oka, Toshimasa ^b   Fukushima, Takeshi ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

d,l kynurenine; d,l tryptophan; Fluorescence; HPLC; R( ) DBD PyNCS

Indexed keywords

AMINO ACIDS; CHIRALITY; COLUMN CHROMATOGRAPHY; ENANTIOMERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SIGNAL TO NOISE RATIO; STEREOCHEMISTRY;

D,L-KYNURENINE; D,L-TRYPTOPHAN; ENANTIOMERIC SEPARATION; FLUORESCENCE DERIVATIZATION; FLUORESCENT LABELING REAGENT; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; L-TRYPTOPHAN; OCTADECYLSILICA; R(-)-DBD-PYNCS;

FLUORESCENCE;

4 (3 ISOTHIOCYANATOPYRROLIDIN 1 YL) 7 (N,N DIMETHYLAMINOSULFONYL) 2,1,3 BENZOXADIAZOLE; KYNURENINE; REAGENT; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DERIVATIZATION; DIASTEREOISOMER; ENANTIOMER; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRE COLUMN FLUORESCENCE DERIVATIZATION; SEPARATION TECHNIQUE; SIGNAL NOISE RATIO; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 79958221133     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1525     Document Type: Article

References (14)

1. Fukushima T, Sone Y, Mitsuhashi S, Tomiya M and Toyo'oka T. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers. Chirality 2009; 21: 468-472.
2. Hartai Z, Juhász A, Rimanóczy Á, Janáky T, Donkó T, Dux L, Penke B, Tóth GK, Janka Z and Kálmán J. Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease. Neurochemistry International 2007; 50: 308-313.
3. Hilmas C, Pereira EFR, Alkondon M, Rassoulpour A, Schwarcz R and Albuquerque EX. The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: Physiopathological implications. Journal of Neuroscience 2001; 21: 7463-7473.
4. Ishii K, Ogaya T, Song Z, Iizuka H and Fukushima T. Changes in the plasma concentrations of d-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers. Chirality 2010 (in press); doi: 10.1002/chir.20850
5. Jin D, Nagakura K, Murofushi S, Miyahara T and Toyo'oka T. Total resolution of 17 dl-amino acids labelled with a fluorescent chiral reagent, R(-)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N, N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazole, by high-performance liquid chromatography. Journal of Chromatography A 1998; 822: 215-224.
6. Jin D, Miyahara T, Oe T and Toyo'oka T. Determination of d-amino acids labeled with fluorescent chiral reagents, R(-)- and S(+)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N, N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazoles, in biological and food samples by liquid chromatography. Analytical Biochemistry 1999; 269: 124-132.
7. Mitsuhashi S, Fukushima T, Arai K, Tomiya M, Santa T, Imai K and Toyo'oka T. Development of a column-switching high-performance liquid chromatography for kynurenine enantiomers and its application to a pharmacokinetic study in rat plasma. Analytica Chimica Acta 2007; 587: 60-66.
8. Ogaya T, Song Z, Ishii K and Fukushima T. Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after d-kynurenine infusion: an in vivo microdialysis study. Neurochemical Research 2010; 35: 559-563.
9. Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA and Roberts RC. Increased cortical kynurenate content in schizophrenia. Biological Psychiatry 2001; 50: 521-530.
10. Song Z, Ogaya T, Ishii K, Ichiba H, Iizuka H and Fukushima T. Utilization of kynurenic acid produced from d-kynurenine in an in vitro assay of d-amino acid oxidase activity. Journal of Health Science 2010; 56: 341-346.
11. Swartz KJ, During MJ, Freese A and Beal MF. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. Journal of Neuroscience 1990; 10: 2965-2973.
12. Toyo'oka T, Toriumi M and Ishii Y. Enantioseparation of beta-blockers labelled with a chiral fluorescent reagent, R(-)-DBD-PyNCS, by reversed-phase liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 1997; 15:1467-1476.
13. Toyo'oka T, Tomoi N, Oe T and Miyahara T. Separation of 17 dl-amino acids and chiral sequential analysis of peptides by reversed-phase liquid chromatography after labeling with R(-)-4- (3-isothiocyanatopyrrolidin-1-yl)-7-(N, N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazole. Analytical Biochemistry 1999; 276: 48-58.
14. Toyo'oka T, Jin D, Tomoi N, Oe T and Hiranuma H. R(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)- 7-(N, N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazole, a fluorescent chiral tagging reagent: sensitive resolution of chiral amines and amino acids by reversed-phase liquid chromatography. Biomedical Chromatography 2001; 15: 56-67.